0001708649-18-000005.txt : 20180710 0001708649-18-000005.hdr.sgml : 20180710 20180710102113 ACCESSION NUMBER: 0001708649-18-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180710 DATE AS OF CHANGE: 20180710 EFFECTIVENESS DATE: 20180710 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CARISMA Therapeutics Inc. CENTRAL INDEX KEY: 0001708649 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-316355 FILM NUMBER: 18946214 BUSINESS ADDRESS: STREET 1: 3025 MARKET STREET STREET 2: SUITE 140 CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: 484-899-0326 MAIL ADDRESS: STREET 1: 3025 MARKET STREET STREET 2: SUITE 140 CITY: PHILADELPHIA STATE: PA ZIP: 19104 FORMER COMPANY: FORMER CONFORMED NAME: CARMA Therapeutics Inc. DATE OF NAME CHANGE: 20170606 D 1 primary_doc.xml X0708 D LIVE 0001708649 CARISMA Therapeutics Inc. 3025 MARKET STREET SUITE 140 PHILADELPHIA PA PENNSYLVANIA 19104 484-899-0326 DELAWARE CARMA Therapeutics Inc. Corporation true 2017 Bruce Peacock 3025 Market Street Suite 140 Philadelphia PA PENNSYLVANIA 19104 Director Steven Kelly 3025 Market Street Suite 140 Philadelphia PA PENNSYLVANIA 19104 Executive Officer Director Margarita Chavez 3025 Market Street Suite 140 Philadelphia PA PENNSYLVANIA 19104 Director Althea Stillman 3025 Market Street Suite 140 Philadelphia PA PENNSYLVANIA 19104 Director Eran Nadav 3025 Market Street Suite 140 Philadelphia PA PENNSYLVANIA 19104 Director Regina Hodits 3025 Market Street Suite 140 Philadelphia PA PENNSYLVANIA 19104 Director Jacob Gunterberg 3025 Market Street Suite 140 Philadelphia PA PENNSYLVANIA 19104 Director Biotechnology Decline to Disclose 06b false 2018-06-26 true true false 0 53174961 26099965 27074996 false 11 0 0 0 false CARISMA Therapeutics Inc. /s/ Steven Kelly Steven Kelly President and Chief Executive Officer 2018-07-05